We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$419M
AUM Growth
-$15.3M
Cap. Flow
+$1.2M
Cap. Flow %
0.29%
Top 10 Hldgs %
26.82%
Holding
332
New
18
Increased
100
Reduced
121
Closed
26

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$3.01M
2
ALB icon
Albemarle
ALB
+$2.71M
3
SXT icon
Sensient Technologies
SXT
+$1.58M
4
AAPL icon
Apple
AAPL
+$987K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$887K

Sector Composition

Rank Sector Weight
1 Financials 11.59%
2 Healthcare 11.5%
3 Communication Services 8.08%
4 Materials 7.92%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
251
DELISTED
Enzo Biochem, Inc.
ENZ
$99K 0.02%
27,827
+2,000
+8% +$6.67K
FSCR
252
DELISTED
FEDERAL SCREW WORKS
FSCR
$96K 0.02%
13,100
MNTX
253
DELISTED
Manitex International, Inc.
MNTX
$90K 0.02%
12,519
-1,000
-7% -$7.45K
AMPE
254
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$89K 0.02%
178
-50
-22% -$23.2K
AXDX
255
DELISTED
Accelerate Diagnostics
AXDX
$87K 0.02%
1,488
MRAM icon
256
Everspin Technologies
MRAM
$341M
$65K 0.02%
10,000
TPHS
257
DELISTED
Trinity Place Holdings Inc.com
TPHS
$61K 0.01%
30,900
PRTK
258
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$53K 0.01%
10,900
+400
+4% +$2.2K
HBP
259
DELISTED
Huttig Building Products, Inc.
HBP
$53K 0.01%
10,000
BLRX
260
BioLineRX
BLRX
$12.3M
$51K 0.01%
467
PFIE
261
DELISTED
Profire Energy, Inc
PFIE
$23K 0.01%
20,100
ECT
262
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$22K 0.01%
31,200
RNWK
263
DELISTED
RealNetworks Inc
RNWK
$16K ﹤0.01%
10,000
TNXP icon
264
Tonix Pharmaceuticals
TNXP
$160M
0
MACE
265
DELISTED
MACE SECURITY INTL INC NEW
MACE
$6K ﹤0.01%
20,150
QCCO
266
DELISTED
QC HLDGS INC
QCCO
$4K ﹤0.01%
10,000
PVCT
267
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
29,750
ALB icon
268
Albemarle
ALB
$13.9B
-16,116
Closed -$2.71M
ARKK icon
269
ARK Innovation ETF
ARKK
$5.66B
-1,799
Closed -$235K
CCI icon
270
Crown Castle
CCI
$33.3B
-1,089
Closed -$212K
CMCSA icon
271
Comcast
CMCSA
$85B
-3,945
Closed -$225K
DIV icon
272
Global X SuperDividend US ETF
DIV
$780M
-10,046
Closed -$201K
GD icon
273
General Dynamics
GD
$104B
-1,126
Closed -$212K
GE icon
274
GE Aerospace
GE
$374B
-2,626
Closed -$176K
GLD icon
275
SPDR Gold Trust
GLD
$131B
-1,484
Closed -$246K

Similar funds

Cutter & Co Brokerage's Q3 2021 Portfolio in Review

As of Q3 2021, Cutter & Co Brokerage held 332 positions worth $419M, down 3.5% from $435M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cutter & Co Brokerage's Q3 2021 filing shows 18 new, 100 increased, 121 reduced and 26 closed positions. Its largest new stake was Palvella Therapeutics: 4,076 shares worth $1.69M. The largest sale was Nutrien, an estimated $3.01M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Cutter & Co Brokerage's largest Q3 2021 buy was Palvella Therapeutics: 4,076 shares worth $1.69M.
  • Cutter & Co Brokerage added most to Mercury Systems in Q3 2021, an estimated $2.18M increase.
  • Cutter & Co Brokerage's biggest Q3 2021 reduction was Sensient Technologies, cutting an estimated $1.58M.
  • Cutter & Co Brokerage fully exited Nutrien in Q3 2021, selling an estimated $3.01M.
  • Cutter & Co Brokerage's ten largest holdings make up 27% of its $419M portfolio in Q3 2021.
  • Cutter & Co Brokerage opened 18 new positions and closed 26 in Q3 2021.
  • Cutter & Co Brokerage's portfolio value fell 3.5% quarter-over-quarter to $419M.

Based on Cutter & Co Brokerage's 13F filing for Q3 2021, filed 2 Nov 2021.